ライフサイエンスコーパス: continuous infusion

1 IU/kg pump prime, and 10,000 KIU/kg per hour continuous infusion).

2 ng for 10 minutes, followed by 0.5 mg/kg/min continuous infusion).

3 concurrent fluorouracil (200 mg/m(2) per day continuous infusion).

4 in 3 days and persisted throughout 7 days of continuous infusion.

5 700, 850, and 1,000 mg/m(2)/d for 4 days via continuous infusion.

6 ected daily but causes severe bone loss with continuous infusion.

7 with FU/LV; FU was administered by bolus or continuous infusion.

8 cause undesirable side effects and require a continuous infusion.

9 No DLT occurred with 24-hour continuous infusion.

10 d two-compartment (biexponential) model with continuous infusion.

11 nge of 2-7 mmol/kg either as a bolus or as a continuous infusion.

12 administered through intrathecal boluses or continuous infusion.

13 efore resuscitation, and 1.5 mL.kg-1.hr-1 by continuous infusion.

14 ay courses of 2-CDA (8.9 mg/m(2)/d) given by continuous infusion.

15 n with paclitaxel, administered as a 96-hour continuous infusion.

16 zodiazepines and opioids, via both bolus and continuous infusion.

17 assigned to intravenous exenatide or placebo continuous infusion.

18 g i.v. bolus injections, as well as by 5-day continuous infusions.

19 nd prefer to administer these medications as continuous infusions.

20 termittent sedative dosing prior to starting continuous infusions.

21 olus of ranitidine (0.5 mg/kg) followed by a continuous infusion (0.1 mg x kg(-1) x hr(-1)).

22 caine (n = 7) bolus (1.5 mg/kg), followed by continuous infusion (100 mg/h for patients >70 kg or 70

23 itial bolus (4 mg/m(2)) and subsequent 4-day continuous infusion (12.5, 15.0, 17.5, or 20.0 mg/m(2)/w

24 Participants underwent two bolus-plus-continuous-infusion 2-FA positron emission tomography sc

25 initial bolus (4 mg/m2) followed by a 4-day continuous infusion (4 mg/m2/d).

26 Weekly gemcitabine with continuous infusion 5-FU is an active combination in pat

27 nistered orally on a schedule that simulates continuous-infusion 5-FU.

28 Continuous infusion (72 h) of varying doses of GGTI in c

29 l 400 mg/m(2), followed by 2400 mg/m(2) 46-h continuous infusion), administered every 2 weeks for a t

30 by means of either a bolus every 12 hours or continuous infusion and at either a low dose (equivalent

31 the same amount of antibody administered by continuous infusion and by split administrations, compar

32 o 10 mg/kg, FU 600 to 800 mg/m(2) (120 hours continuous infusion), and hydroxyurea from 500 to 1,000

33 eated with at least one parenteral (bolus or continuous infusion) antihypertensive agent.

34 (2) by either a 1-hour infusion (Arm A) or a continuous infusion (Arm B) for 3, 5, or 7 days before a

35 either a 2-hour daily infusion (arm A) or a continuous infusion (arm B).

36 udy groups received morphine (boluses and/or continuous infusion) as rescue medication on the guidanc

37 xed-onium chlorofumarate 24a following a 1 h continuous infusion at 10-20 microg/kg/min (95-100% bloc

38 Daunorubicin was administered as a 72-hour continuous infusion at 34 or 45 mg/m2/d [corrected].

39 domly assigned to receive levosimendan (in a continuous infusion at a dose of 0.025 to 0.2 mug per ki

40 eated with a single 7-day course of 2-CdA by continuous infusion at a dose of 0.1 mg/kg per day.

41 ver a 10-minute period; this was followed by continuous infusion at a rate of 1 mug/kg/h until imagin

42 After 4 weeks of continuous infusion at a rate of 22.5 microg/day, GDNF h

43 ur O6-BG infusion at 120 mg/m2 followed by a continuous infusion at an initial dose of 30 mg/m2/d for

44 aline when given as an intravenous bolus and continuous infusion attenuates water content of small bo

45 m(2) daily and fluorouracil (FU) 400 mg/m(2) continuous infusion (CI) daily for the final 10 days of

46 ed to determine the feasibility of combining continuous-infusion (CI) paclitaxel with concurrent radi

47 ts were enrolled onto 2-, 4-, 7-, and 14-day continuous-infusion cohorts.

48 unorubicin 90 mg/m(2) per day for 3 days and continuous-infusion cytarabine 100 mg/m(2) per day for 7

49 s 4 to 6), and cytarabine 1.5 g/m(2) IV as a continuous infusion daily for 3 or 4 days (days 4 to 7).

50 g regimen consisted of cisplatin (25 mg/m(2) continuous infusion daily for 4 days), fludarabine (30 m

51 mg/m(2)), day 0; 5-FU (1,000 mg/m(2)/d), by continuous infusion days 0 to 2; and VCR (1.5 mg/m(2)),

52 Moreover, A-582941 continuous infusion decreased phosphorylation of tau in

53 monthly, and high-dose pulses of in-patient continuous infusion decrescendo IL-2 (54 MIU/m(2)) over

54 ent resistance, which can be overcome with a continuous infusion device.

55 The continuous-infusion dose that resulted in undetectable A

56 was to define the maximum-tolerated dose of continuous-infusion doxorubicin administered with standa

57 The maximum-tolerated dose of continuous-infusion doxorubicin combined with standard p

58 al-beam radiation with concurrent fixed-dose continuous-infusion doxorubicin followed by surgical res

59 Concurrent continuous-infusion doxorubicin was administered by an i

60 The maximum-tolerated dose of continuous-infusion doxorubicin with standard preoperati

61 administered to a total dose of 50.4 Gy with continuous-infusion doxorubicin.

62 l/kg/min human BNP-32 once administered as a continuous infusion during 4 h.

63 ol amino acid solution was administered as a continuous infusion during burn intensive care unit stay

64 gimen by adding fludarabine to dose-adjusted continuous-infusion etoposide, prednisone, vincristine,

65 Paclitaxel was administered as a 120-hour continuous infusion every 3 weeks during the course of r

66 el feature, UCN-01 is administered as a 72-h continuous infusion every 4 weeks (in second and subsequ

67 provide virus suppression equivalent to the continuous-infusion exposure.

68 dition of weekly oxaliplatin to preoperative continuous infusion fluorouracil (FU) and external-beam

69 terial floxuridine combined with intravenous continuous-infusion fluorouracil (chemotherapy arm, 53 p

70 e-to-one ratio to epirubicin, cisplatin, and continuous-infusion fluorouracil (ECF), irinotecan plus

71 oxicity and possibly enhanced activity makes continuous-infusion fluorouracil (FU) an attractive alte

72 included cisplatin 20 mg/m(2) for 4 days and continuous-infusion fluorouracil 1,000 mg/m(2)/d for 4 d

73 reated with blinatumomab in cycles of 4-week continuous infusion followed by a 2-week treatment-free

74 ered on cardiopulmonary bypass followed by a continuous infusion for >/=12 hours and </=5 days after

75 Decitabine was administered at 2 mg/kg/d via continuous infusion for 168 hours.

76 120 mg/m2 of O6-BG over 1 hour followed by a continuous infusion for 2 days at escalating doses presu

77 inistering the antagonists as a subcutaneous continuous infusion for 2 weeks compared to a single bol

78 ients received 1.5 g/m(2) per day cytarabine continuous infusion for 3 days and laromustine 600 mg/m(

79 nder the curve of 6.5, followed by TOPO as a continuous infusion for 3 days; the starting dose of TOP

80 d 11 h), and bleomycin (25 units per day, by continuous infusion for 5 days on days 10-14; two cycles

81 ight patients received cladribine 12 mg/m(2) continuous infusion for 5 days with melphalan 180 mg/m(2

82 mg/m2, weekly; arm E, 5-FU 750 mg/m2/d IV by continuous infusion for 5 days, then 750 mg/m2 weekly, a

83 9-AC 35 microg/m(2)/h was administered by continuous infusion for 72 hours every 2 weeks via ambul

84 vopiridol (50 mg/m(2)/d) was administered by continuous infusion for 72 hours every 2 weeks, and resp

85 tered initially at a dose of 50 mg/m(2)/d by continuous infusion for 72 hours every 2 weeks.

86 patients at a dose of 0.1 mg/kg as a 24-hour continuous infusion for a total of 7 days each cycle.

87 Study drug was administered as a continuous infusion for the duration of mechanical venti

88 infusion) or ciclosporin (2 mg/kg per day by continuous infusion for up to 7 days, followed by twice-

89 was performed every 8 hrs in lumens without continuous infusions for the duration of catheter placem

90 stases were treated with weekly oxaliplatin, continuous infusion FU 200 mg/m2 intravenously, and RT.

91 , the addition of oxaliplatin to intravenous continuous infusion FU and RT for patients with locally

92 A regimen of weekly oxaliplatin, continuous infusion FU, and radiation therapy is now bei

93 15) was developed to compare the efficacy of continuous-infusion FU (CIFU) plus levamisole to FU/LV p

94 25 g of human serum albumin every 8 hrs with continuous infusion furosemide, or dual placebo, targete

95 To discuss the use of continuous infusions, general anesthesia, hypothermia, a

96 ot statistically different between bolus and continuous-infusion groups.

97 ents with pneumonia who received extended or continuous infusion had lower mortality than those recei

98 of 200 mg/day in four divided doses or as a continuous infusion in a dose of 240 mg/day (10 mg/hr) f

99 s, and arginine butyrate was administered by continuous infusion in an intrapatient dose escalation,

100 Paclitaxel administered as a 120-hour continuous infusion in combination with radiotherapy is

101 administration of beta-lactam antibiotics by continuous infusion in critically ill patients with seve

102 ed ara-C doses of 1 to 2 gm/m(2)/d, given by continuous infusion in IA, and over 2 to 4 hours in FA a

103 armacokinetics of a 96-hour intravenous (IV) continuous infusion in patients with advanced cancer.

104 h-dose (100 U/kg bolus followed by age-based continuous infusion in randomized children) vs low-dose

105 e., approximately EC(95)]) administered as a continuous infusion in vitro provides virtually complete

106 All continuous infusions in the surgical intensive care unit

107 stered through either intrathecal boluses or continuous infusion induced a dose-dependent downregulat

108 ively, were given sedation or analgesia as a continuous infusion, intermittent doses, or both (p<0.00

109 and 194 eligible patients were randomized to continuous infusion intravenous IL-2 (9 million units/m(

110 Furthermore, continuous infusion is associated with a decreased likel

111 hat received intravenous bolus followed by a continuous infusion, lung water content was significantl

112 linical data suggest that administration via continuous infusion may result in enhanced antitumor act

113 ulmonary arterial hypertension (PAH) require continuous infusions, multiple inhalations, or oral admi

114 ients were studied for 33 closed-loop and 21 continuous infusion nights.

115 tumors, (2) evaluate the safety of extending continuous-infusion O6-BG at the optimal dose with intra

116 evels of less than 10 fmol/mg protein with a continuous-infusion O6-BG dose of 30 mg/m2/d.

117 sing a conventional dosing of 16 g/2 g/24 hr continuous infusion, obese patients were more likely tha

118 ficantly greater risk of nephrotoxicity than continuous infusion (odds ratio = 8.204; p </= 0.001).

119 icrog/kg bolus i.v. over 2 min followed by a continuous infusion of 0.1 microg/kg per min) and a high

120 ous loading dose of 0.45 mg/kg followed by a continuous infusion of 0.15 mg x kg(-1) x hr(-1).

121 All animals except naive rats received continuous infusion of 0.9% saline at 0.5 mL/hr througho

122 d either to 3 mg/kg Bbeta15-42 followed by a continuous infusion of 1 mg/kg/hr for 5 hours (pFX06; n

123 icrog/kg bolus i.v. over 2 min followed by a continuous infusion of 1 microg/kg per min), significant

124 Site 2 received a continuous infusion of 10 mM L-NAME to inhibit NO syntha

125 njection of 2 nmol ghrelin was followed by a continuous infusion of 12 nmol ghrelin via a primed 200-

126 180 microg/kg boluses 10 min apart and as a continuous infusion of 2 microg/kg per min) during percu

127 400 mg/m(2) intravenously on day 1 and then continuous infusion of 2,400 mg/m(2) over the next 46 ho

128 o 180-microg/kg boluses 10 minutes apart and continuous infusion of 2.0 microg/kg per minute), starte

129 e randomly allocated 1:1 either to receive a continuous infusion of 200 mg of hydrocortisone for 5 da

130 Chemotherapy with either fluorouracil (continuous infusion of 250 mg/m2 per day; n = 230) or ge

131 A continuous infusion of 3% saline on a sliding scale was

132 Patients received a 7-day continuous infusion of 3, 5, or 7 mg/kg/d of G3139 every

133 bolus of 120 mg/m2 over 1 hour followed by a continuous infusion of 30 mg/m2/d for 48 hours.

134 mg/mL per min per day for 4 days, etoposide continuous infusion of 338 mg/m(2) per day for 4 days, a

135 A continuous infusion of 4 mug/kg per day thyroxine for 42

136 s (control), or injured animals treated with continuous infusion of 7-nitroindazole, a specific neuro

137 Ten men and eight women received a primed-continuous infusion of [1,1,2,3,3-(2)H(5)]glycerol and c

138 of age) were studied during 8.5 h of primed continuous infusion of [1,2-(1)(3)C]leucine with intermi

139 infusion of [1,1,2,3,3-(2)H(5)]glycerol and continuous infusion of [1-(13)C]palmitate to measure gly

140 Subjects received a primed continuous infusion of [3,3,3-(2)H]lactate and [6,6-(2)H

141 nts with Parkinson's disease, long-acting or continuous infusion of a dopaminergic drug reduces the r

142 aising intragastric pH on the first day as a continuous infusion of a histamine-2-receptor antagonist

143 and LHA from groups of male rats treated by continuous infusion of aCSF or lactate into the caudal f

144 In contrast, continuous infusion of AMD, although increasing EPCs in

145 hBNP-054 or vehicle in 6 dogs that received continuous infusion of ANG II to induce hypertension.

146 mice compared with littermate controls after continuous infusion of Ang II.

147 at 6 months of age, followed 1 week later by continuous infusion of angiotensin II (1 microg/kg per m

148 one site of mouse aorta (elastase model) or continuous infusion of angiotensin II in hyperlipidemic

149 Continuous infusion of ANP into the splenic artery (10 n

150 kg of anti-rat NPCT antibody was followed by continuous infusion of anti-NPCT (16 mug per hour) via a

151 Continuous infusion of apelin at a rate of 0.01 microg/m

152 d melphalan regimen consisted of carboplatin continuous infusion of area under the plasma concentrati

153 ponse of lymphocytes in leukemic patients to continuous infusion of blinatumomab helps to better unde

154 all patients of a phase 2 study responded to continuous infusion of blinatumomab in a strikingly simi

155 s lower among patients receiving extended or continuous infusion of carbapenems or piperacillin/tazob

156 randomized studies suggests that extended or continuous infusion of carbapenems or piperacillin/tazob

157 In two groups (C(40)C and C(20)C), continuous infusion of CGX--1007 was administered over 8

158 induction chemotherapy including 4 cycles of continuous infusion of combinations of dexamethasone, vi

159 ntravenously to male adult rats, followed by continuous infusion of curcumin (0.24 micromol/day) for

160 A 168-hour continuous infusion of decitabine is well tolerated and

161 ved for a 2-h period before the AH by primed continuous infusion of di-deuterated 6,6[2H2]glucose (1.

162 2,100 mg/m2/d on days 1 and 2, and a 72-hour continuous infusion of doxorubicin 75 mg/m2 and vincrist

163 Continuous infusion of doxorubicin is as effective as bo

164 diac outcomes in children receiving bolus or continuous infusion of doxorubicin.

165 d) or intermittent air (IA; control) and (2) continuous infusion of either 50% dextrose or saline (co

166 A 72-hour continuous infusion of either glucagon-like peptide-1 (1

167 randomly allocated at H6 to receive a 42-hr continuous infusion of either hydrocortisone at 200 mg/d

168 Inotropic support with continuous infusion of epinephrine was being administere

169 e randomly assigned 77 patients to receive a continuous infusion of esmolol titrated to maintain hear

170 nderwent partial pancreatectomy, followed by continuous infusion of EXE or saline (SAL) for 14 weeks.

171 In vivo, continuous infusion of exogenous HGF markedly diminished

172 Continuous infusion of fenoldopam or placebo for up to 4

173 Chemoradiation with a continuous infusion of fluorouracil (250 mg/m2 per day)

174 were fluid overloaded, and were receiving a continuous infusion of furosemide (> or =6 mg/kg/day).

175 We hypothesized that the addition of continuous infusion of glucagon-like peptide-1 to intens

176 vers and in livers of male mice feminized by continuous infusion of growth hormone (GH).

177 In vivo, continuous infusion of HGF in the rat remnant kidney mod

178 Continuous infusion of HP-beta-CD into the ventricular s

179 oncentrate complex (hPCC; 2.5 mL/kg, n = 2), continuous infusion of hPCC (1.0 mL/h, n = 1) or continu

180 inuous infusion of hPCC (1.0 mL/h, n = 1) or continuous infusion of human recombinant factor VIIa (1

181 Early and continuous infusion of hypertonic saline in patients wit

182 creases in lung and brain water content with continuous infusion of hypertonic saline may have therap

183 GFR was measured simultaneously using a continuous infusion of I-iothalamate and external radioa

184 Continuous infusion of interferon-gamma resulted in hema

185 A post-column continuous infusion of internal standard (nigericin) wit

186 Continuous infusion of ISO also increased ICER in the ra

187 Isoproterenol testing was performed with continuous infusion of isoproterenol (45 mug/min) for 3

188 Desensitization was then induced by a 2-hour continuous infusion of isoproterenol, and venodilatation

189 A primed continuous infusion of L-[1-(13)C] leucine was used to m

190 ined duodenal mucosa samples during a primed continuous infusion of L-[1-(13)C]leucine.

191 A primed continuous infusion of l-[ring-(13)C6] phenylalanine wit

192 ol intravenously as boluses before and after continuous infusion of L748337 (a specific beta3 antagon

193 Lactic acidosis developed during continuous infusion of linezolid while oxygen consumptio

194 Despite the delay in effect onset, continuous infusion of lorazepam, preceded by a bolus lo

195 umulated significantly in patients receiving continuous infusion of lorazepam.

196 Continuous infusion of low levels of growth hormone redu

197 estigate the effect of an acute injection or continuous infusion of LPS on experimentally induced hyp

198 Continuous infusion of LPS through mini-osmotic pumps wa

199 atic transection CRPS model is reversed by a continuous infusion of MP (3 mg/kg/day over 21 days), an

200 with an ED(50) of 1.2 mg/kg/day for a 14-day continuous infusion of MP, and a maximum inhibitory effe

201 7) We suggest that patients receiving a continuous infusion of neuromuscular-blocking agent rece

202 neuromuscular blockade in patients receiving continuous infusion of neuromuscular-blocking agents.

203 od, fetuses were given a bolus followed by a continuous infusion of Nomega-nitro-L-arginine methyl es

204 this hypothesis, rats were made tolerant by continuous infusion of NTG for 3 days (10 microgram kg(-

205 The dose of the continuous infusion of O6-BG escalated until tumor AGT w

206 connected to osmotic pumps that delivered a continuous infusion of patients' or control cerebrospina

207 After continuous infusion of phenylephrine (20 mg/kg per day)

208 he kinase suppressor of ras-1 (KSR1) gene by continuous infusion of phosphorothioate antisense oligon

209 We then used a continuous infusion of radiolabeled FFA to measure direc

210 electively stimulated VEGFR-1 and VEGFR-2 by continuous infusion of receptor-specific ligands or sele

211 after subtotal nephrectomy, rats received a continuous infusion of recombinant HGF, neutralization o

212 after subtotal nephrectomy, rats received a continuous infusion of recombinant HGF, neutralization o

213 Site 1 served as a control and received a continuous infusion of Ringer solution.

214 In urethane-anaesthetised rats continuous infusion of saline into the bladder (6 ml h(-

215 Furthermore, a continuous infusion of SDF-1 into the rabbit proximal ti

216 ith a subcutaneous minipump that delivered a continuous infusion of secreted products from the model

217 tion interruption (defined as cessation of a continuous infusion of sedation agent) were identified.

218 echanically ventilated patients prescribed a continuous infusion of sedative medication while in the

219 th dextran sulphate sodium (DSS) followed by continuous infusion of soy lipid-based PN solution throu

220 p (n = 91) received a weight-based bolus and continuous infusion of T4 according to the organ procure

221 locked unilaterally in dorsal hippocampus by continuous infusion of tetrodotoxin (TTX).

222 The animals were subjected to 2 wks of continuous infusion of the betaAR agonist isoproterenol.

223 aneous implantation of a morphine pellet and continuous infusion of the delta-opioid receptor antagon

224 cardiotoxicity can be prevented in adults by continuous infusion of the drug, but mechanisms of cardi

225 On 1 day they received continuous infusion of the GLP-1 receptor antagonist exe

226 16 open-chest dogs: 8 controls and 8 given a continuous infusion of the GPI tirofiban, starting 45 mi

227 In mice where hyperalgesia subsided after continuous infusion of the highest morphine dose (i.e.,

228 ature osmotic pumps, we now demonstrate that continuous infusion of these cytokines for 7 days had a

229 en because its high fibrin affinity obviates continuous infusion of this thrombolytic agent.

230 s, pulmonary hypertension was induced by the continuous infusion of U46619, a thromboxane A2 analog.

231 Pulmonary hypertension was produced by the continuous infusion of U46619, a thromboxane A2 mimetic.

232 This large dataset supports the use of continuous infusion of vancomycin in critically ill pati

233 l; group 2, vancomycin twice daily; group 3, continuous infusion of vancomycin; and group 4, linezoli

234 In addition, six sham animals (not injured, continuous infusion of vehicle) were used to obtain refe

235 c oxide synthase group was administered with continuous infusion of ZK 234238 started 1 hr postinjury

236 h sessions, participants received bolus plus continuous infusions of 2-FA, were scanned for 1 h after

237 ein turnover were determined by using primed continuous infusions of [(2)H(5)]phenylalanine and [1-(1

238 inhibitor may be an alternative to high-dose continuous infusions of a histamine-2-receptor antagonis

239 abbits underwent intrathecal cannulation and continuous infusions of either 300 microg/ml recombinant

240 d 2002, 222 patients were treated with 4-day continuous infusions of fluorouracil (1,000 mg/m2/d) and

241 ted at rest and after exercise during primed continuous infusions of l-[ring-(2)H5]phenylalanine and

242 Continuous infusions of magnesium for 5 days given to pa

243 f patients with delirium (CAM-ICU+) received continuous infusions of midazolam (59% vs. 32%, p < .05)

244 assured, and all patients were sedated using continuous infusions of midazolam and/or fentanyl; no ch

245 el and eyelid closure for patients receiving continuous infusions of neuromuscular-blocking agents.

246 en the analyses were adjusted for the use of continuous infusions of opioids and/or sedatives and ven

247 ho were receiving mechanical ventilation and continuous infusions of sedative drugs in a medical inte

248 entilation was provided during sedation with continuous infusions of sufentanil and midazolam.

249 oprotection, and biomechanics under acute or continuous infusions of the apelinergic agonists ELA or

250 G3139 was delivered by continuous infusion on days 1 to 10.

251 ach on day 1 plus fluorouracil 750 mg/m(2)/d continuous infusion on days 1 to 5 every 3 weeks (DCF) o

252 ) on day 1 plus fluorouracil 1,000 mg/m(2)/d continuous infusion on days 1 to 5 every 4 weeks (CF).

253 , and 3), cytarabine (100 mg/m(2) per day by continuous infusion on days 1-7), and GO (6 mg/m(2) on d

254 ne reduced 25% plus interleukin-2 by 24-hour continuous infusion (on days 5 to 8, 17 to 20, and 26 to

255 ified, the schedule was changed to a 24-hour continuous infusion once weekly (starting dose, 300 mg/m

256 m(2) bolus followed by 2,400 mg/m(2) 46-hour continuous infusion, once every 2 weeks) or gemcitabine

257 A second group of rats were treated with continuous infusion only for 48 hrs of either 7.5% hyper

258 y was administered by bolus as compared with continuous infusion or at a high dose as compared with a

259 nd the advantages of administration of FU by continuous infusion or bolus.

260 ed intravenously (with intermittent bolus or continuous infusion) or intramuscularly.

261 mug/kg bolus followed by 0.1/0.2 mug/kg/min continuous infusion) or placebo.

262 every 21 days, ifosfamide 9 g/m2 over 3 days continuous infusion, or ifosfamide 3 g/m2 per day in 3 h

263 , patients can be treated with higher doses, continuous infusions, or the addition of a thiazide diur

264 Continuous infusion over 2 to 3 weeks appears preferable

265 /m(2) in combination with mesna 5000 mg/m(2) continuous infusion over 24 h, days 1 and 2; one dose of

266 ssitated the administration of BR96-Dox as a continuous infusion over 24 hours and use of antiemetics

267 cated that the higher dose of 10 mg given as continuous infusion over 24 hours had the most favorable

268 a phase I study of weekly XR5000 by 120-hour continuous infusion over 3 weeks.

269 (2), LV 400 mg/m(2), and FU 1,400 mg/m(2) by continuous infusion over 48 hours, with the same FUDR do

270 ts by repeated intermittent injections or by continuous infusion over 6 days.

271 Medications delivered by continuous infusion, particularly those that are weight

272 nts, median z score = -0.70 SD, P =.006; for continuous-infusion patients, median z score = -0.765, P

273 ay) underwent a [(11)C]raclopride bolus-plus-continuous-infusion PET session.

274 he authors used [(11)C]raclopride bolus-plus-continuous-infusion positron emission tomography (PET) t

275 odilatation has been shown to decline during continuous infusion, possibly suggestive of an internali

276 tween formulas based on single-injection and continuous-infusion reference methods.

277 use of either intermittent bolus sedation or continuous infusion sedation targeting specific titratio

278 using either intermittent bolus sedation or continuous infusion sedation with daily interruptions or

279 ICU) patients are frequently managed using a continuous-infusion sedative.

280 that it provides long-term cardioprotection; continuous infusions should be eliminated from pediatric

281 g intravenous bolus along with a 10 mg/kg/hr continuous infusion starting just before reperfusion and

282 nine (O6-BG) administered intravenously as a continuous infusion that suppresses O6-alkylguanine-DNA

283 During the continuous infusion, the mean steady-state ranitidine co

284 Prolonged or continuous infusion therapy has improved microbiological

285 the clinical evidence base for prolonged or continuous infusion therapy is insufficiently strong to

286 In the comparison of bolus with continuous infusion, there was no significant difference

287 agent such as alteplase is an alternative to continuous-infusion thrombolytic regimens and minimizes

288 diation (fluorouracil 225 mg/m(2) per day by continuous infusion throughout radiotherapy, and 45.0 Gy

289 hypothesis, IFN-gamma was administered as a continuous infusion to Fancc-/- and wild-type (WT) mice

290 human clinical trials comparing prolonged or continuous infusion to intermittent injection have faile

291 rmittent bolus administration or propofol by continuous infusion to maintain a Ramsay score of 2-3.

292 uscular blockers, which were administered as continuous infusions to 146 (7%) of these neonates.

293 double-blind, randomized controlled trial of continuous infusion versus intermittent bolus dosing of

294 by intermittent intraperitoneal injection or continuous infusion via an implanted infusion pump.

295 njury from the intraparenchymal catheter and continuous infusion was confined primarily to a narrow z

296 Continuous infusion with ATK throughout 72h of reperfusi

297 is phase I study of relapsed/refractory NHL, continuous infusion with CD19-targeted immunotherapy bli

298 adolescent rats on postnatal days 30-47 via continuous infusion with implanted osmotic minipumps, us

299 ase II dose of G3139 is 7 mg/kg/d as a 7-day continuous infusion, with cyclophosphamide 500 mg/m2/d a

300 (112 mug/d; n = 2) dosing of blinatumomab by continuous infusion, with dexamethasone prophylaxis, in